Rupesh Shekhawat

Department of Community Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Medical Sciences, Sawangi, Wardha, Maharashtra, India

Publications

  • Review Article   
    Efficacy and Response of SARS-CoV-2 Vaccine in Transplant Patients of Solid Organs
    Author(s): Anubha Jain*, Guddi Laishram and Rupesh Shekhawat

    Despite the fact that the Coronavirus Severe Acute Respiratory Syndrome (SARS-CoV-2) pandemic has exposed many shortcomings to our health system and society, there have been remarkable scientific achievements: we are now in 2019. Vaccines that cause severe Coronavirus disease can be given to effectively prevent it. Within a year of the outbreak of a pandemic (COVID-19). The outbreak of Coronavirus has a major impact on Solid Organ Transplantation (SOT). Because of the on-going treatment to suppress the immune system of the transplant patients and other medical conditions prevailing in them, SOT patients are at a greater risk and have increase chances of developing COVID-19. SOT recipients have reported mortality rates of over 13% to 30%. The SARS-CoV-2 vaccine has been developed at an unparalleled rate for the COVID-19 pandemic; also 14 SARS-CoV-2 vaccines are cur.. Read More»

    Abstract HTML PDF